Journal
JOURNAL OF INORGANIC BIOCHEMISTRY
Volume 153, Issue -, Pages 253-258Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jinorgbio.2015.08.027
Keywords
Cisplatin; Proteasome; Neuroblastoma; Lactacystin
Funding
- Italian Space Agency (ASI SMEMCO) [DC-DTE-2011-033]
Ask authors/readers for more resources
Cisplatin is a widely used chemotherapy drug which exerts cytotoxic activity by affecting both nuclear and cytosolic pathways. Herewith, we report, for the first time, that cisplatin inhibits proteasome activity in vitro. Cisplatin induces a dose dependent inhibition of the three enzymatic activities of proteasome (Le., the chymotrypsin-like activity, the trypsin-like activity and the caspase-like activity). Moreover, cisplatin administration to neuroblastoma cells brings about a fast loss of proteasome particle activity, which is followed by a de novo synthesis of proteasome. Lastly, we report that the simultaneous administration of lactacystin and cisplatin enhances the cytotoxicity of cisplatin alone. The overall bulk of data opens to an intriguing scenario, concerning the biological effects of cisplatin in the control of cellular life, which goes beyond the well established genotoxic effect. (C) 2015 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available